Toward optimal screening strategies for older women. Costs, benefits, and harms of breast cancer screening by age, biology, and health status.

Department of Oncology, Georgetown University Medical Center, Lombardi Comprehensive Cancer Center, Washington, DC, USA.
Journal of General Internal Medicine (Impact Factor: 3.42). 07/2005; 20(6):487-96.
Source: PubMed


Optimal ages of breast cancer screening cessation remain uncertain.
To evaluate screening policies based on age and quartiles of life expectancy (LE).
We used a stochastic model with proxies of age-dependent biology to evaluate the incremental U.S. societal costs and benefits of biennial screening from age 50 until age 70, 79, or lifetime.
Discounted incremental costs per life years saved (LYS).
Lifetime screening is expensive (151,434 dollars per LYS) if women have treatment and survival comparable to clinical trials (idealized); stopping at age 79 costs 82,063 dollars per LYS. This latter result corresponds to costs associated with an LE of 9.5 years at age 79, a value expected for 75% of 79-year-olds, about 50% of 80-year-olds, and 25% of 85-year-olds. Using actual treatment and survival patterns, screening benefits are greater, and lifetime screening of all women might be considered (114,905 dollars per LYS), especially for women in the top 25% of LE for their age (50,643 dollars per LYS, life expectancy of approximately 7 years at age 90).
If all women receive idealized treatment, the benefits of mammography beyond age 79 are too low relative to their costs to justify continued screening. However, if treatment is not ideal, extending screening beyond age 79 could be considered, especially for women in the top 25% of life expectancy for their age.

Download full-text


Available from: Robin Yabroff
  • Source
    • "The authors concluded that extending screening beyond age 79 may be reasonable for women in the top quartile of life expectancies [47] "
    [Show abstract] [Hide abstract]
    ABSTRACT: The proportions both of elderly patients in the world and of elderly patients with cancer are both increasing. In the evaluation of these patients, physiologic age, and not chronologic age, should be carefully considered in the decision-making process prior to both cancer screening and cancer treatment in an effort to avoid ageism. Many tools exist to help the practitioner determine the physiologic age of the patient, which allows for more appropriate and more individualized risk stratification, both in the pre- and postoperative periods as patients are evaluated for surgical treatments and monitored for surgical complications, respectively. During and after operations in the oncogeriatric populations, physiologic changes occuring that accompany aging include impaired stress response, increased senescence, and decreased immunity, all three of which impact the risk/benefit ratio associated with cancer surgery in the elderly.
    Full-text · Article · Jan 2012 · The Scientific World Journal
  • Source
    • "Additionally, there are potential implications of this model in terms of policy debate and establishing screening guidelines should future developments warrant them. As has been the case with mammograms [32], pap smears [33] and colorectal cancer screening [34,35], modeling can be a valuable tool in framing questions related to screening and defining a range of parameters within which society can benefit. Recently published results on screening for prostate cancer highlight a potential benefit from early stage modeling when determining the net benefits to patients and society [36]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Alzheimer's Disease (AD) affects a growing proportion of the population each year. Novel therapies on the horizon may slow the progress of AD symptoms and avoid cases altogether. Initiating treatment for the underlying pathology of AD would ideally be based on biomarker screening tools identifying pre-symptomatic individuals. Early-stage modeling provides estimates of potential outcomes and informs policy development. A time-to-event (TTE) simulation provided estimates of screening asymptomatic patients in the general population age > or =55 and treatment impact on the number of patients reaching AD. Patients were followed from AD screen until all-cause death. Baseline sensitivity and specificity were 0.87 and 0.78, with treatment on positive screen. Treatment slowed progression by 50%. Events were scheduled using literature-based age-dependent incidences of AD and death. The base case results indicated increased AD free years (AD-FYs) through delays in onset and a reduction of 20 AD cases per 1000 screened individuals. Patients completely avoiding AD accounted for 61% of the incremental AD-FYs gained. Total years of treatment per 1000 screened patients was 2,611. The number-needed-to-screen was 51 and the number-needed-to-treat was 12 to avoid one case of AD. One-way sensitivity analysis indicated that duration of screening sensitivity and rescreen interval impact AD-FYs the most. A two-way sensitivity analysis found that for a test with an extended duration of sensitivity (15 years) the number of AD cases avoided was 6,000-7,000 cases for a test with higher sensitivity and specificity (0.90,0.90). This study yielded valuable parameter range estimates at an early stage in the study of screening for AD. Analysis identified duration of screening sensitivity as a key variable that may be unavailable from clinical trials.
    Full-text · Article · Apr 2010 · BMC Medical Informatics and Decision Making
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Objectives: Identification of the characteristics of women who have a low regard for Breast Self-Examination (BSE), mammography (MM), Pap testing (PAP); of psychosocial barriers in their way to visiting the gynecologist for routine gynecological examinations; and if a correlation exists between cervical and breast cancer screening. Methods: This study included 848 Romanian women, aged 18-82, who had started their sexual life. In 2007 the women were questioned regarding receiving the examinations and tests mentioned above. In 2010 we also organized two focus groups of 20 women. The Chi square test, binary logistic regression and latent class analysis were employed. Results: The proportion of BSE monthly is very low and the proportion of no self-examination is very high in the 15-24 years and over 50 years age groups. Only 15% of the interviewed women had had an MM. The proportion of the women who had had an MM in the age group under 44 years is almost double compared with the proportion in the group 44 years and older (χ 2 =10.5, df=1, p=0.001). Less than half of the interviewed women had received a routine gynecological examination in the last 3 years. Conclusions: In respect of genital and breast health attitudes the women are distributed in four latent classes.
    Full-text · Article ·
Show more